Jul. 13, 2011 (Baystreet.ca) --
Crystal Research Associates has published a new research report on BELLUS Health Inc.. The full report is available at: http://www.baystreet.ca/articles/research_reports/research_reports.aspx.
Crystal Research Associates Issues Research Report on BELLUS Health Inc.
Earlier from BELLUS Health
- BELLUS Health reports results for first quarter ended March 31, 2011
- BELLUS Health delivering on key strategic partnerships and KIACTA(tm) phase III development
- BELLUS Health issues shares in final payment for the exercise of its lease termination option
- BELLUS Health and the agahan group enter into broad license for VIVIMIND(tm) in the Middle East
- BELLUS Health completes restructuring initiatives with repatriation of intellectual property to canada
Later from BELLUS Health
- BELLUS Health reports results for second quarter ended June 30, 2011
- BELLUS Health reports results for third quarter ended September 30, 2011, and provides update on VIVIMIND(tm) partnerships
- OVOS Natural Health Inc. launches VIVIMIND(tm) in Canada
- BELLUS Health and Integris Pharma Ltd. enter into exclusive license agreement for VIVIMIND(tm) in Greece and Cyprus
- BELLUS Health reports results for year ended December 31, 2011, and provides update on KIACTA(tm) phase 3 confirmatory study
Follow BELLUS Health into a list and get an email when it puts out news.
Follow BELLUS Health